Contact
searchSearch
HMP Global

Stroke & Neurovascular Interventions

Features

LAA Occluders
Late-Breaking One-Year Data Show Abbott's Next-Generation Amulet 360™ Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke
11/03/2026
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year...
11/03/2026
Vascular Disease Management
Stroke Interventions
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures
07/17/2026
Imperative Care announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation neurovascular guidewire purpose-built to improve vascular access during stroke procedures.
Imperative Care announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation neurovascular guidewire purpose-built to improve vascular access during stroke procedures.
Imperative Care announced the...
07/17/2026
Vascular Disease Management
Interview
New Insights on Thrombectomy in Atrial Fibrillation-Related Stroke
05/06/2026
Waseem Wahood, MD
Dr Wahood discusses trends reshaping the landscape of mechanical thrombectomy for acute ischemic stroke, particularly in patients with atrial fibrillation.
Dr Wahood discusses trends reshaping the landscape of mechanical thrombectomy for acute ischemic stroke, particularly in patients with atrial fibrillation.
Dr Wahood discusses trends...
05/06/2026
Vascular Disease Management
Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Neurovascular Care
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/10/2026
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's...
03/10/2026
Vascular Disease Management
New Stroke Guidelines
New Guideline Expands Stroke Treatment for Adults, Offers First Pediatric Stroke Guidance
02/19/2026
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke...
02/19/2026
Vascular Disease Management
Carotid Artery Disease
Medtronic Launches Full Distribution of the Neuroguard IEP™ System, Establishing a New Era in Treating Patients With Carotid Artery Disease
10/14/2025
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical...
10/14/2025
Vascular Disease Management
Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
Interview
Carotid Webs in Young Women: Diagnosis and Treatment
02/12/2025
Bruce Perler, MD
At VEITH 2024, Bruce Perler, MD, MBA, gave a presentation entitled “Carotid Webs: An Important Etiology of Devastating Strokes, Especially in Young Women.” VDM spoke with Dr Perler about the best ways to diagnose and treat carotid webs.
At VEITH 2024, Bruce Perler, MD, MBA, gave a presentation entitled “Carotid Webs: An Important Etiology of Devastating Strokes, Especially in Young Women.” VDM spoke with Dr Perler about the best ways to diagnose and treat carotid webs.
At VEITH 2024, Bruce Perler, MD,...
02/12/2025
Vascular Disease Management
Stroke Treatment
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that...
02/10/2025
Vascular Disease Management

Videos

Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Videos
Urgent Carotid Endarterectomy in a COVID-19 Patient: Standard Approach With Some Adjustments (Video 1)
05/07/2020
05/07/2020
Vascular Disease Management
LINC 2020
Kölbel: Stroke in TEVAR
02/28/2020
Tilo Kölbel, MD
Tilo Kölbel, MD
Tilo Kölbel, MD
02/28/2020
Vascular Disease Management
Tim Wittig, MD
AMP 2026
Primary Outcomes of the MOTIV BTK Sirolimus-Eluting Bioresorbable Vascular Scaffold for the Treatment of Infrapopliteal Lesions
10/20/2026
Tim Wittig, MD
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his...
10/20/2026
Vascular Disease Management
Zola N'Dandu, MD
AMP 2026
Unmet Needs in Deep Venous Arterialization Technology
10/07/2026
Zola N'Dandu, MD
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one...
10/07/2026
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
Healing That Lasts: Real-World 90-Day Outcomes Demonstrating the Durability of Serration Remodeling Therapy
10/06/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his AMP 2026 presentation on serration remodeling therapy.
Mike Watts, MD, FSIR, discusses his AMP 2026 presentation on serration remodeling therapy.
Mike Watts, MD, FSIR, discusses...
10/06/2026
Vascular Disease Management
Fadi Saab MD
AMP 2026
Lessons Learned Throughout the Deep Venous Arterialization Evolution: Yesterday and Today
09/29/2026
Fadi Saab, MD, FACC, FSCAI
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional...
09/29/2026
Vascular Disease Management
Jill Sommerset RVT
AMP 2026
Pre-op Mapping for Deep Vein Arterialization
09/28/2026
Jill Sommerset, RVT
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU,...
09/28/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Failing Deep Vein Arterialization: Early Detection and Timely Reintervention Strategies
09/22/2026
Yana Etkin, MD, FSVS, FACS
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD,...
09/22/2026
Vascular Disease Management
Dr Anahita Dua speaks at AMP 2026
AMP 2026
The Changing Face of Chronic Limb-Threatening Ischemia: Global Epidemiology and the Untold Data Story
09/10/2026
Anahita Dua, MD, MS, MBA, FACS
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the changing face of CLTI.
Dr Anahita Dua discusses the...
09/10/2026
Vascular Disease Management
Dr N'Dandu speaks at AMP 2026
AMP 2026
Woundosome for Wound Healing
09/01/2026
Zola N'Dandu, MD
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the woundosome concept and its impact on outcomes in patients with chronic limb-threatening ischemia.
Dr Zola N'Dandu discusses the...
09/01/2026
Vascular Disease Management
Marianne Brodmann, MD, speaks at AMP 2026.
AMP 2026
Long-Term Evidence From DEEPER OUS
08/25/2026
Marianne Brodmann, MD
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses the latest results from the DEEPER OUS trial.
Dr Marianne Brodmann discusses...
08/25/2026
Vascular Disease Management
Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management

About Us

Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), educates readers on the latest advancements in endovascular treatment strategies. 

Learn more about ISET and AMP and register for the events here:

ISET logo

AMP logo

Subscribe Now!

Vascular Disease Management Newsletter

News

LAA Occluders
Late-Breaking One-Year Data Show Abbott's Next-Generation Amulet 360™ Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke
11/03/2026
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year...
11/03/2026
Vascular Disease Management
Stroke Interventions
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures
07/17/2026
Imperative Care announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation neurovascular guidewire purpose-built to improve vascular access during stroke procedures.
Imperative Care announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation neurovascular guidewire purpose-built to improve vascular access during stroke procedures.
Imperative Care announced the...
07/17/2026
Vascular Disease Management
Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Neurovascular Care
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/10/2026
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's...
03/10/2026
Vascular Disease Management
New Stroke Guidelines
New Guideline Expands Stroke Treatment for Adults, Offers First Pediatric Stroke Guidance
02/19/2026
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke...
02/19/2026
Vascular Disease Management
Carotid Artery Disease
Medtronic Launches Full Distribution of the Neuroguard IEP™ System, Establishing a New Era in Treating Patients With Carotid Artery Disease
10/14/2025
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical...
10/14/2025
Vascular Disease Management
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
Stroke Treatment
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that...
02/10/2025
Vascular Disease Management
Stroke Solutions
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
02/05/2025
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features...
02/05/2025
Vascular Disease Management
Stroke Advocacy
Philips and Medtronic Advocacy Partnership Aims to Help Accelerate Access to Life-saving Treatments
10/24/2024
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the...
10/24/2024
Vascular Disease Management
LAA Occluders
Late-Breaking One-Year Data Show Abbott's Next-Generation Amulet 360™ Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke
11/03/2026
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year...
11/03/2026
Vascular Disease Management
Intravascular Lithotripsy
Abbott's TECTONIC Clinical Trial Demonstrates Strong 30-day Outcomes and High Procedural Success for Its Investigational SonicForce™ Coronary Intravascular Lithotripsy System
11/03/2026
11/03/2026
Vascular Disease Management
Stroke Clinical Trials
Could A Drug for Leg Cramps Prevent a Second, Deadlier Stroke? 
10/30/2026
The trial is funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is open to patients diagnosed within the last six months with an ischemic stroke or high-risk transient ischemic attack (TIA).
The trial is funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is open to patients diagnosed within the last six months with an ischemic stroke or high-risk transient ischemic attack (TIA).
The trial is funded by the...
10/30/2026
Cath Lab Digest
Radiation Safety
Rampart Launches Vanguard™ at TCT 2026, Extending Total-Body Radiation Protection to Interventional Imagers
10/29/2026
Purpose-built head-of-table solution advances the Shed the Lead® movement as new multisociety guidance calls for enhanced radiation protection.
Purpose-built head-of-table solution advances the Shed the Lead® movement as new multisociety guidance calls for enhanced radiation protection.
Purpose-built head-of-table...
10/29/2026
Vascular Disease Management
Peripheral Arterial Bleeds
Instylla's Embrace® Hydrogel Embolic System Receives FDA Approval for Peripheral Arterial Bleeds
10/29/2026
10/29/2026
Vascular Disease Management
Large-Bore Closure
Haemonetics Announces FDA Approval of PerQseal Elite Vascular Closure System
10/27/2026
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system...
10/27/2026
Cath Lab Digest
FDA Approvals
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
10/20/2026
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra,...
10/20/2026
Cath Lab Digest
Vertex PE System (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Publication of SPIRARE II Pivotal Trial Results Showing Vertex Thrombectomy System Normalized Hemodynamics in 50% of Pulmonary Embolism Patients
10/19/2026
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the...
10/19/2026
Cath Lab Digest
Endovascular Aortic Repair
FDA Approves GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis for Expanded use in FEVAR and BEVAR
10/15/2026
10/15/2026
Vascular Disease Management
Deep Learning
Deep Learning Model Predicts Hepatocellular Carcinoma Progression Following Transarterial Chemoembolization
10/09/2026
Laura Simson, MA
A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.
A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.
A prediction model combining...
10/09/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use